Cargando…
Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
Furosemide is a diuretic frequently used in the therapeutic management of edema associated with cardiac, renal, and hepatic failure and hypertension. However, there are a very low number of pharmaceutical dosage forms containing furosemide that are suitable for children under 6- years old. Therefore...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022368/ https://www.ncbi.nlm.nih.gov/pubmed/35464657 http://dx.doi.org/10.4103/japtr.japtr_325_21 |
_version_ | 1784690067466354688 |
---|---|
author | Sombié, Charles Bavouma Guetambaba, J. E. Kéré Diawara, Hermine Zimé Yaméogo, Josias Ouédraogo, Salfo Goole, Jonathan Semdé, Rasmané |
author_facet | Sombié, Charles Bavouma Guetambaba, J. E. Kéré Diawara, Hermine Zimé Yaméogo, Josias Ouédraogo, Salfo Goole, Jonathan Semdé, Rasmané |
author_sort | Sombié, Charles Bavouma |
collection | PubMed |
description | Furosemide is a diuretic frequently used in the therapeutic management of edema associated with cardiac, renal, and hepatic failure and hypertension. However, there are a very low number of pharmaceutical dosage forms containing furosemide that are suitable for children under 6- years old. Therefore, there is a real need to develop hospital preparations, especially in the hospital. Four oral pediatric solutions of furosemide (2 mg/Ml) were formulated. Two of those solutions did not contain ethanol. For each formulation, 12 batches of 1600.0 Ml were prepared and packaged in 250.0 Ml brown glass bottles with polypropylene screw caps. The physicochemical properties (visual appearance, pH, osmolarity, drug content) and microbiological quality of the finished product were determined on the freshly prepared solutions and after 90 days of storage at 30°C/65% RH. The physicochemical and microbiological characteristics of the freshly prepared solutions were within the prescribed specifications. After 90 days of storage at 30°C/65% RH, the solutions containing sucrose and those without ethanol showed a slight decrease in pH and furosemide content of about 2.5%–4.5% (w/w). Despite this slight decrease, the characteristics remained within the prescribed specifications. Based on the stability profile of the ethanol-free solution containing sorbitol, it could be implemented in hospitals for the care of pediatric patients. |
format | Online Article Text |
id | pubmed-9022368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-90223682022-04-22 Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study Sombié, Charles Bavouma Guetambaba, J. E. Kéré Diawara, Hermine Zimé Yaméogo, Josias Ouédraogo, Salfo Goole, Jonathan Semdé, Rasmané J Adv Pharm Technol Res Original Article Furosemide is a diuretic frequently used in the therapeutic management of edema associated with cardiac, renal, and hepatic failure and hypertension. However, there are a very low number of pharmaceutical dosage forms containing furosemide that are suitable for children under 6- years old. Therefore, there is a real need to develop hospital preparations, especially in the hospital. Four oral pediatric solutions of furosemide (2 mg/Ml) were formulated. Two of those solutions did not contain ethanol. For each formulation, 12 batches of 1600.0 Ml were prepared and packaged in 250.0 Ml brown glass bottles with polypropylene screw caps. The physicochemical properties (visual appearance, pH, osmolarity, drug content) and microbiological quality of the finished product were determined on the freshly prepared solutions and after 90 days of storage at 30°C/65% RH. The physicochemical and microbiological characteristics of the freshly prepared solutions were within the prescribed specifications. After 90 days of storage at 30°C/65% RH, the solutions containing sucrose and those without ethanol showed a slight decrease in pH and furosemide content of about 2.5%–4.5% (w/w). Despite this slight decrease, the characteristics remained within the prescribed specifications. Based on the stability profile of the ethanol-free solution containing sorbitol, it could be implemented in hospitals for the care of pediatric patients. Wolters Kluwer - Medknow 2022 2022-04-07 /pmc/articles/PMC9022368/ /pubmed/35464657 http://dx.doi.org/10.4103/japtr.japtr_325_21 Text en Copyright: © 2022 Journal of Advanced Pharmaceutical Technology & Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Sombié, Charles Bavouma Guetambaba, J. E. Kéré Diawara, Hermine Zimé Yaméogo, Josias Ouédraogo, Salfo Goole, Jonathan Semdé, Rasmané Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study |
title | Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study |
title_full | Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study |
title_fullStr | Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study |
title_full_unstemmed | Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study |
title_short | Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study |
title_sort | hospital preparations of ethanol-free furosemide oral solutions: formulation and stability study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022368/ https://www.ncbi.nlm.nih.gov/pubmed/35464657 http://dx.doi.org/10.4103/japtr.japtr_325_21 |
work_keys_str_mv | AT sombiecharlesbavouma hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy AT guetambabajekere hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy AT diawaraherminezime hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy AT yameogojosias hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy AT ouedraogosalfo hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy AT goolejonathan hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy AT semderasmane hospitalpreparationsofethanolfreefurosemideoralsolutionsformulationandstabilitystudy |